(-)-epigallocatechin 3-gallate multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DLGAP5 mRNA CTD PMID:22079256 1,2-dichloroethane decreases expression ISO Dlgap5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of DLGAP5 mRNA CTD PMID:28960355 1-chloro-2,4-dinitrobenzene decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Dinitrochlorobenzene results in decreased expression of DLGAP5 mRNA CTD PMID:17374397 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of DLGAP5 mRNA CTD PMID:30723492 17beta-estradiol increases expression ISO DLGAP5 (Homo sapiens) 6480464 Estradiol results in increased expression of DLGAP5 mRNA CTD PMID:18310284 and PMID:19167446 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of DLGAP5 mRNA CTD PMID:32145629 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Dlgap5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO DLGAP5 (Homo sapiens) 6480464 2 more ... CTD PMID:31173147 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Dlgap5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Dlgap5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DLGAP5 mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DLGAP5 mRNA CTD PMID:33387578 and PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Dlgap5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DLGAP5 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO DLGAP5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of DLGAP5 mRNA CTD PMID:22298810 2-butoxyethanol increases expression ISO Dlgap5 (Mus musculus) 6480464 n-butoxyethanol results in increased expression of DLGAP5 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO DLGAP5 (Homo sapiens) 6480464 beta-methylcholine affects the expression of DLGAP5 mRNA CTD PMID:21179406 2-palmitoylglycerol increases expression ISO DLGAP5 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of DLGAP5 mRNA CTD PMID:37199045 3-methylcholanthrene increases expression ISO Dlgap5 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of DLGAP5 mRNA CTD PMID:20713471 4,4'-sulfonyldiphenol increases expression ISO DLGAP5 (Homo sapiens) 6480464 bisphenol S results in increased expression of DLGAP5 mRNA CTD PMID:27685785 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Oxazolone results in decreased expression of DLGAP5 mRNA CTD PMID:17374397 4-hydroxynon-2-enal decreases expression ISO Dlgap5 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of DLGAP5 mRNA CTD PMID:19191707 4-hydroxynon-2-enal increases expression ISO Dlgap5 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in increased expression of DLGAP5 mRNA CTD PMID:19191707 5-aza-2'-deoxycytidine affects expression ISO DLGAP5 (Homo sapiens) 6480464 Decitabine affects the expression of DLGAP5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DLGAP5 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of DLGAP5 mRNA CTD PMID:31881176 acrylamide decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Acrylamide results in decreased expression of DLGAP5 mRNA CTD PMID:32763439 adefovir pivoxil increases expression ISO DLGAP5 (Homo sapiens) 6480464 adefovir dipivoxil results in increased expression of DLGAP5 mRNA CTD PMID:25596134 aflatoxin B1 affects expression ISO DLGAP5 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of DLGAP5 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of DLGAP5 mRNA CTD PMID:32234424 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of DLGAP5 mRNA CTD PMID:23630614 and PMID:25378103 aflatoxin M1 decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Aflatoxin M1 results in decreased expression of DLGAP5 mRNA CTD PMID:30928695 all-trans-retinoic acid decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of DLGAP5 mRNA CTD PMID:33167477 antimycin A increases expression ISO DLGAP5 (Homo sapiens) 6480464 Antimycin A results in increased expression of DLGAP5 mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO DLGAP5 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of DLGAP5 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression ISO Dlgap5 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of DLGAP5 mRNA CTD PMID:23650126 azathioprine decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Azathioprine results in decreased expression of DLGAP5 mRNA CTD PMID:22623647 benzo[a]pyrene increases expression ISO Dlgap5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of DLGAP5 mRNA CTD PMID:20713471 and PMID:32417428 benzo[a]pyrene increases methylation ISO DLGAP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of DLGAP5 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of DLGAP5 mRNA CTD PMID:20064835 more ... benzo[a]pyrene diol epoxide I decreases expression ISO DLGAP5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 and PMID:20382639 benzo[e]pyrene increases methylation ISO DLGAP5 (Homo sapiens) 6480464 benzo(e)pyrene results in increased methylation of DLGAP5 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of DLGAP5 mRNA CTD PMID:25102026 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DLGAP5 mRNA CTD PMID:25181051 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DLGAP5 mRNA CTD PMID:32145629 bisphenol A decreases expression ISO DLGAP5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of DLGAP5 mRNA CTD PMID:29275510 bisphenol A affects expression ISO DLGAP5 (Homo sapiens) 6480464 bisphenol A affects the expression of DLGAP5 mRNA CTD PMID:30903817 bisphenol A affects localization ISO DLGAP5 (Homo sapiens) 6480464 bisphenol A affects the localization of DLGAP5 protein CTD PMID:30980863 bortezomib multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of DLGAP5 mRNA CTD PMID:25522274 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of DLGAP5 mRNA CTD PMID:32479839 cadmium atom decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Cadmium results in decreased expression of DLGAP5 mRNA CTD PMID:21120746 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of DLGAP5 mRNA CTD PMID:25993096 cadmium dichloride affects expression ISO DLGAP5 (Homo sapiens) 6480464 Cadmium Chloride affects the expression of DLGAP5 mRNA CTD PMID:25596134 caffeine affects phosphorylation ISO DLGAP5 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of DLGAP5 protein CTD PMID:35688186 calcitriol multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DLGAP5 mRNA CTD PMID:21592394 calcitriol decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Calcitriol results in decreased expression of DLGAP5 mRNA CTD PMID:21592394 CGP 52608 multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to DLGAP5 gene] CTD PMID:28238834 chloroacetaldehyde affects expression ISO DLGAP5 (Homo sapiens) 6480464 chloroacetaldehyde affects the expression of DLGAP5 mRNA CTD PMID:25596134 chlorpyrifos decreases expression ISO Dlgap5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of DLGAP5 mRNA CTD PMID:37019170 cidofovir anhydrous increases expression ISO DLGAP5 (Homo sapiens) 6480464 Cidofovir results in increased expression of DLGAP5 mRNA CTD PMID:25596134 cisplatin multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of DLGAP5 mRNA] CTD PMID:21858171 cisplatin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of DLGAP5 mRNA CTD PMID:25596134 and PMID:27594783 cisplatin affects expression ISO DLGAP5 (Homo sapiens) 6480464 Cisplatin affects the expression of DLGAP5 mRNA CTD PMID:23300844 clodronic acid increases expression ISO DLGAP5 (Homo sapiens) 6480464 Clodronic Acid results in increased expression of DLGAP5 mRNA CTD PMID:25596134 cobalt dichloride decreases expression ISO DLGAP5 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of DLGAP5 mRNA CTD PMID:19320972 and PMID:19376846 copper atom multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DLGAP5 mRNA CTD PMID:20971185 copper atom increases expression EXP 6480464 Copper results in increased expression of DLGAP5 mRNA CTD PMID:30556269 copper(0) multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of DLGAP5 mRNA CTD PMID:20971185 copper(0) increases expression EXP 6480464 Copper results in increased expression of DLGAP5 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of DLGAP5 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO DLGAP5 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of DLGAP5 protein CTD PMID:35688186 coumestrol increases expression ISO DLGAP5 (Homo sapiens) 6480464 Coumestrol results in increased expression of DLGAP5 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 CU-O LINKAGE decreases expression ISO DLGAP5 (Homo sapiens) 6480464 cupric oxide results in decreased expression of DLGAP5 mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of DLGAP5 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of DLGAP5 mRNA CTD PMID:20106945 more ... deguelin increases expression ISO DLGAP5 (Homo sapiens) 6480464 deguelin results in increased expression of DLGAP5 mRNA CTD PMID:33512557 diallyl trisulfide decreases expression ISO DLGAP5 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of DLGAP5 mRNA CTD PMID:34995734 diazinon affects expression EXP 6480464 Diazinon affects the expression of DLGAP5 mRNA CTD PMID:22546817 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of DLGAP5 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO DLGAP5 (Homo sapiens) 6480464 Dibutyl Phthalate results in increased expression of DLGAP5 mRNA CTD PMID:36828243 dibutyl phthalate multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 N-methyl-delta-3 more ... CTD PMID:36828243 dichloroacetic acid increases expression ISO Dlgap5 (Mus musculus) 6480464 Dichloroacetic Acid results in increased expression of DLGAP5 mRNA CTD PMID:28962523 dicrotophos decreases expression ISO DLGAP5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of DLGAP5 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of DLGAP5 mRNA CTD PMID:22546817 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DLGAP5 mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of DLGAP5 mRNA CTD PMID:33729688 doxorubicin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of DLGAP5 mRNA CTD PMID:29803840 and PMID:30031762 Enterolactone multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DLGAP5 mRNA CTD PMID:19167446 ethanol multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of DLGAP5 mRNA CTD PMID:29432896 eugenol decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Eugenol results in decreased expression of DLGAP5 mRNA CTD PMID:17374397 fenpyroximate increases expression ISO DLGAP5 (Homo sapiens) 6480464 fenpyroximate results in increased expression of DLGAP5 mRNA CTD PMID:33512557 folic acid multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of DLGAP5 mRNA CTD PMID:24657277 formaldehyde decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of DLGAP5 mRNA CTD PMID:23649840 FR900359 decreases phosphorylation ISO DLGAP5 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of DLGAP5 protein CTD PMID:37730182 furan increases expression EXP 6480464 furan results in increased expression of DLGAP5 mRNA CTD PMID:25539665 genistein affects expression ISO DLGAP5 (Homo sapiens) 6480464 Genistein affects the expression of DLGAP5 mRNA CTD PMID:18847459 genistein decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Genistein results in decreased expression of DLGAP5 mRNA CTD PMID:22228119 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DLGAP5 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO DLGAP5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of DLGAP5 mRNA CTD PMID:23410634 ivermectin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Ivermectin results in decreased expression of DLGAP5 protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of DLGAP5 mRNA CTD PMID:17639512 leflunomide decreases expression ISO DLGAP5 (Homo sapiens) 6480464 leflunomide results in decreased expression of DLGAP5 mRNA CTD PMID:28988120 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of DLGAP5 mRNA CTD PMID:24136188 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of DLGAP5 mRNA CTD PMID:35283115 lipopolysaccharide multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLGAP5 mRNA CTD PMID:35811015 lucanthone decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Lucanthone results in decreased expression of DLGAP5 mRNA CTD PMID:21148553 menadione affects expression ISO DLGAP5 (Homo sapiens) 6480464 Vitamin K 3 affects the expression of DLGAP5 mRNA CTD PMID:20044591 and PMID:23410634 metformin increases expression EXP 6480464 Metformin results in increased expression of DLGAP5 mRNA CTD PMID:25596134 methamphetamine decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Methamphetamine results in decreased expression of DLGAP5 mRNA CTD PMID:25290377 methapyrilene increases methylation ISO DLGAP5 (Homo sapiens) 6480464 Methapyrilene results in increased methylation of DLGAP5 intron CTD PMID:30157460 methotrexate multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of DLGAP5 mRNA CTD PMID:24657277 methotrexate decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Methotrexate results in decreased expression of DLGAP5 mRNA CTD PMID:24657277 N-methyl-4-phenylpyridinium decreases expression ISO DLGAP5 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of DLGAP5 mRNA CTD PMID:24810058 N-Nitrosopyrrolidine decreases expression ISO DLGAP5 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of DLGAP5 mRNA CTD PMID:32234424 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of DLGAP5 mRNA CTD PMID:22546817 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DLGAP5 mRNA CTD PMID:25729387 ozone decreases expression ISO Dlgap5 (Mus musculus) 6480464 Ozone results in decreased expression of DLGAP5 mRNA CTD PMID:24336422 ozone multiple interactions ISO Dlgap5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DLGAP5 mRNA more ... CTD PMID:25658374 more ... palbociclib decreases expression ISO DLGAP5 (Homo sapiens) 6480464 palbociclib results in decreased expression of DLGAP5 mRNA CTD PMID:22869556 paracetamol decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of DLGAP5 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of DLGAP5 mRNA CTD PMID:33387578 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 PCB138 multiple interactions ISO Dlgap5 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 phenobarbital increases expression ISO Dlgap5 (Mus musculus) 6480464 Phenobarbital results in increased expression of DLGAP5 mRNA CTD PMID:23091169 phytoestrogen increases expression ISO DLGAP5 (Homo sapiens) 6480464 Phytoestrogens results in increased expression of DLGAP5 mRNA CTD PMID:18310284 picoxystrobin increases expression ISO DLGAP5 (Homo sapiens) 6480464 picoxystrobin results in increased expression of DLGAP5 mRNA CTD PMID:33512557 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DLGAP5 mRNA CTD PMID:19162173 piroxicam increases expression ISO DLGAP5 (Homo sapiens) 6480464 Piroxicam results in increased expression of DLGAP5 mRNA CTD PMID:21858171 piroxicam multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in increased expression of DLGAP5 mRNA] CTD PMID:21858171 potassium chromate multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of DLGAP5 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO DLGAP5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of DLGAP5 mRNA CTD PMID:22079256 progesterone decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Progesterone results in decreased expression of DLGAP5 mRNA CTD PMID:21795739 propanal decreases expression ISO DLGAP5 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of DLGAP5 mRNA CTD PMID:26079696 pyrogallol increases expression ISO Dlgap5 (Mus musculus) 6480464 Pyrogallol results in increased expression of DLGAP5 mRNA CTD PMID:20362636 quercetin multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of DLGAP5 mRNA CTD PMID:17639512 quercetin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Quercetin results in decreased expression of DLGAP5 mRNA CTD PMID:21632981 resveratrol multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of DLGAP5 mRNA CTD PMID:19167446 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of DLGAP5 mRNA CTD PMID:28374803 rotenone increases expression ISO DLGAP5 (Homo sapiens) 6480464 Rotenone results in increased expression of DLGAP5 mRNA CTD PMID:33512557 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of DLGAP5 mRNA CTD PMID:35811015 senecionine increases expression EXP 6480464 senecionine results in increased expression of DLGAP5 mRNA CTD PMID:32419051 silicon dioxide decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of DLGAP5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Dlgap5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of DLGAP5 mRNA CTD PMID:29341224 sodium arsenite multiple interactions ISO Dlgap5 (Mus musculus) 6480464 sodium arsenite inhibits the reaction [E2F1 protein binds to DLGAP5 promoter] and sodium arsenite promotes the reaction [E2F4 protein binds to DLGAP5 promoter] CTD PMID:17998272 sodium arsenite decreases expression ISO DLGAP5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of DLGAP5 protein CTD PMID:30528433 sodium arsenite increases expression ISO DLGAP5 (Homo sapiens) 6480464 sodium arsenite results in increased expression of DLGAP5 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO Dlgap5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of DLGAP5 mRNA CTD PMID:17998272 sulforaphane increases expression ISO DLGAP5 (Homo sapiens) 6480464 sulforaphane results in increased expression of DLGAP5 mRNA CTD PMID:31838189 sunitinib decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Sunitinib results in decreased expression of DLGAP5 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO Dlgap5 (Mus musculus) 6480464 Tamoxifen results in decreased expression of DLGAP5 mRNA CTD PMID:17555576 tebufenpyrad increases expression ISO DLGAP5 (Homo sapiens) 6480464 4-chloro-N-((4-(1 and 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of DLGAP5 mRNA CTD PMID:33512557 tert-butyl hydroperoxide increases expression ISO Dlgap5 (Mus musculus) 6480464 tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA CTD PMID:15003993 tert-butyl hydroperoxide affects expression ISO DLGAP5 (Homo sapiens) 6480464 tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA CTD PMID:23410634 testosterone multiple interactions ISO DLGAP5 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DLGAP5 mRNA CTD PMID:21592394 testosterone decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Testosterone results in decreased expression of DLGAP5 mRNA CTD PMID:21592394 thalidomide decreases expression ISO Dlgap5 (Mus musculus) 6480464 Thalidomide results in decreased expression of DLGAP5 mRNA CTD PMID:26217789 thapsigargin increases expression ISO Dlgap5 (Mus musculus) 6480464 Thapsigargin results in increased expression of DLGAP5 protein CTD PMID:24648495 thapsigargin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Thapsigargin results in decreased expression of DLGAP5 mRNA CTD PMID:22378314 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DLGAP5 mRNA CTD PMID:23411599 and PMID:34492290 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of DLGAP5 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of DLGAP5 mRNA CTD PMID:25729387 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of DLGAP5 gene CTD PMID:27618143 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DLGAP5 mRNA CTD PMID:33387578 triclosan decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Triclosan results in decreased expression of DLGAP5 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO Dlgap5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of DLGAP5 mRNA CTD PMID:19042947 triptonide decreases expression ISO Dlgap5 (Mus musculus) 6480464 triptonide results in decreased expression of DLGAP5 mRNA CTD PMID:33045310 troglitazone decreases expression ISO DLGAP5 (Homo sapiens) 6480464 troglitazone results in decreased expression of DLGAP5 mRNA CTD PMID:19140230 trovafloxacin decreases expression ISO Dlgap5 (Mus musculus) 6480464 trovafloxacin results in decreased expression of DLGAP5 mRNA CTD PMID:35537566 tungsten decreases expression ISO Dlgap5 (Mus musculus) 6480464 Tungsten results in decreased expression of DLGAP5 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of DLGAP5 mRNA CTD PMID:22378314 and PMID:29453283 valproic acid affects expression ISO DLGAP5 (Homo sapiens) 6480464 Valproic Acid affects the expression of DLGAP5 mRNA CTD PMID:25979313 valproic acid decreases expression ISO DLGAP5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of DLGAP5 mRNA CTD PMID:27188386 and PMID:28001369 vorinostat increases expression ISO DLGAP5 (Homo sapiens) 6480464 vorinostat results in increased expression of DLGAP5 mRNA CTD PMID:27188386 zinc atom increases expression ISO DLGAP5 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of DLGAP5 mRNA CTD PMID:22171008 zinc(0) increases expression ISO DLGAP5 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of DLGAP5 mRNA CTD PMID:22171008 zoledronic acid decreases expression ISO DLGAP5 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of DLGAP5 mRNA CTD PMID:24714768 and PMID:25596134